Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs

STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
ShareXFacebook

Bristol Myers Squibb and China's Hengrui Pharma are teaming up to advance more than a dozen early-stage drugs, in a deal worth up to $15.2 billion.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement